Krystal Biotech (KRYS) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

KRYS is expected to report earnings to rise 90.57% to $1.01 per share on November 04

Krystal Biotech KRYS Stock Earnings Reports

Q3'24

Est.

$1.01

Q2'24

Missed

by $0.25

Q1'24

Missed

by $0.28

Q4'23

Beat

by $0.59

Q3'23

Beat

by $4.04

The last earnings report on August 05 showed earnings per share of 52 cents, missing the estimate of 77 cents. With 182.10K shares outstanding, the current market capitalization sits at 5.09B.

View a ticker or compare two or three

Compare

KRYS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For KRYS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for KRYS (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company which provides therapies for rare and orphan diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

2100 Wharton Street

Phone

+1 412 586-5830

Employees

229

Web

https://www.krystalbio.com